Skip to content
‹ Back to IndustriesSoftware & Technology

Iodine Intelligence: Unlocking the power of CONCURRENT

AI and NLP are revolutionizing healthcare by improving data utilization. Despite the vast amount of data in the health industry, much remains underutilized due to technological limitations. Iodine's CONCURRENT software prioritizes patient care with AI and machine learning, addressing challenges like misalignment of clinical evidence and documentation.

This story was produced through MarketScale. See how Software & Technology teams put it to work with Executive Thought Leadership.

By Lauren Hickey · ·
Share
Iodine Intelligence: Unlocking the power of CONCURRENT

Key takeaways

01

AI and NLP are significantly transforming healthcare technology by enhancing data utilization.

02

30% of the world’s data is generated by the healthcare industry, expected to exceed 36% in three years.

03

Iodine’s CONCURRENT platform uses AI to prioritize patient care by addressing misalignments between clinical evidence and documentation.

Free workspace

Turn your Software & Technology expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Artificial intelligence (AI) and Natural Language Processing (NLP) are taking over the health industry and renovating healthcare technology. It has for some time now being a Lodestar into improving and delivering quality healthcare. A ton of information is being collected but isn’t being utilized simply because the existing technology doesn’t know what to do with the data. A recent report from RBC Capital Markets states 30% of the world’s data is generated in the healthcare industry, and it is expected to surpass 36% in the next three years. Handling this sort of information is a challenge as most healthcare AI technology relies on simple technologies like rules and checklists.

On this episode, Lauren Hickey, the content strategist at Iodine, chats with Diana O’Connor, the clinical product consultant manager at Iodine, and Justin Geradot, the client service operations manager at Iodine, about their new flagship technology, CONCURRENT. Hickey, Diana, and Justin chat about…

  1. What can prevent CDIs from fully adopting concurrent.
  2. How auto-assignment works
  3. Barriers and quiet periods.

“CONCURRENT is our flagship software that utilizes artificial intelligence and machine learning to prioritize patients concurrently while in-house. It uses, at a high level, different amount of misalignment of information between clinical evidence that support a certain condition and the actual expectation documentation of those conditions and uses the difference to prioritize,” said Justin.

“CDI is complex. There is a lot of different workflow strategies that people use. CONCURRENT is more than just a technical implementation, we are taking account of different philosophies and workflows,” said Diana.

Lauren then asked Justin about auto-assignment and quiet periods, and he went on to say:

“Auto assignment is a way concurrent distributes cases to CDS’s for review. It is one of the oldest features for CONCURRENT specifically to address the problem that scope changes as a result of CONCURRENT. Before CONCURRENT, CDIs way to locate cases was through location or service line. When prioritization is added, balancing for caseloads gets more difficult. Auto assignment instead of using service line to distribute cases uses priority status, assigning cases with more priority first then working their way down.”

“Quiet period is how much period a case must incubate before its considered for auto-assignment. This is a change for a lot of CDI departments. A lot of CDI teams want to see cases every two days at a minimum. With prioritization, we set a 24hr quiet period to get the necessary information. After a case has been reviewed, it goes into another quiet period for 12hrs to make sure it doesn’t immediately get reprioritized again,” Justin continued.

Lauren then talks about query hesitancy and asks Diana about CDSs not querying as much even when Iodine AI says a query is needed. Diana’s reply:

“One of the things we are looking for is a complete, intact medical record that tells the story of the patient and the sooner we get the documentation in, the better. And with denials coming up the way they are, you want continuity of them in the medical record. It’s a shift from getting querying away as a penalty into more as a prompt and querying sooner.”

At the end of the episode, Justin says Iodine and Concurrent are always changing, adding new functionalities, platforms, and configurations—Retrospect being an example.

Your experts belong here

Every story in MarketScale Software & Technology starts with a company putting its solutions engineers, product teams, and customer engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Buyers ask AI engines who to consider, and published expert answers are what those engines cite.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

LH
Lauren Hickey
B2B Weekly

The week in Software & Technology, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Software & Technology: are you visible to AI?

Before they reach out, Software & Technology buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Software & Technology expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your solutions engineers, product teams, and customer engineers into the articles, video, and social content Software & Technology buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Software & Technology Insights

CISA confirms PHP2Shell exploitation and gives federal agencies until Oct. 29 to patch

CISA confirms PHP2Shell exploitation and gives federal agencies until Oct. 29 to patch

Both PHP2Shell CVEs entered the KEV catalog on October 26 with a three-day federal civilian deadline under BOD 26-04; fixed versions are 8.5.12, 8.4.27, 8.3.36 and 8.2.35.

  • 01Both PHP2Shell CVEs entered the KEV catalog on October 26 with a three-day federal deadline under BOD 26-04; fixed versions are 8.5.12, 8.4.27, 8.3.36 and 8.2.35.
  • 02A Perplexity researcher logged 35 successful shell executions on honeypots, though the setup may not reflect production, and Delft University tracked 50,000+ exploit requests from 600+ IPs.

Oct 28, 2026

Zoom's 2030 growth target rests on customers buying more than meetings

Zoom's 2030 growth target rests on customers buying more than meetings

Zoom Communications gave its first time-bound long-range target at Zoomtopia 2026: 6% to 8% revenue growth in fiscal 2030. The target includes double-digit growth in enterprise revenue. Phone reaches only 29% of Meetings enterprise accounts today.

  • 01Zoom Phone sits in 29% of Zoom's enterprise Meetings accounts, and the fiscal 2030 growth plan reads largely as a bet on the other 71%.
  • 02Customers on three or more Zoom products had 43% lower dollar churn than customers on one or two, which Zoom cited as support for its land-and-expand strategy.
  • 03Zoom's non-current remaining performance obligations rose 25%, which Chang tied to larger, longer-term and multi-product platform agreements. For buyers weighing Phone or Contact Center, contract length is worth a close look.

Oct 27, 2026

Anthropic just filed to go public with $16.3 billion in six-month revenue

Anthropic just filed to go public with $16.3 billion in six-month revenue

Anthropic filed its S-1 on October 26 to list Class A shares on Nasdaq under the ticker ANT. The filing reports about $16.3 billion in revenue for the first half of 2026 and an $80.7 billion net loss. Share count and price range are not yet set. The same day, four financial firms announced $63 billion to lease Broadcom chips to the company.

  • 01First-half 2026 revenue was about $16.3 billion, against $4.6 billion for all of 2025, per Yahoo Finance's read of the filing.
  • 02The net loss for the half was $80.7 billion, while second-quarter operating income was $974 million.
  • 03Some insiders can trade on the first day, with more than 20 unlock windows over about a year.

Oct 27, 2026

Explore More Software & Technology Insights

Read more expert perspectives from across Software & Technology.

Browse Software & Technology Hub

About the Experts

LH
Lauren Hickey

Content Strategist at Iodine

Lauren Hickey is a content strategist at Iodine. She engages with experts to explore how AI and NLP are transforming healthcare technology. Her work focuses on effective data utilization in the health industry.

DO
Diana O’Connor

Clinical Product Consultant Manager

Iodine

Diana O’Connor is a clinical product consultant manager at Iodine. She contributes her expertise to the development of healthcare solutions that leverage AI and machine learning.

JG
Justin Geradot

Client Service Operations Manager

Iodine

Justin Geradot is the client service operations manager at Iodine. He specializes in implementing flagship technologies like CONCURRENT to enhance clinical documentation improvement processes.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Software & Technology and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512